Join us and your life science colleagues for an open, engaging and informative discussion around the best ways for small life science companies to raise capital to generate big value.
This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring 2017.
|3.00 pm — 3:30 pm||Coffee and Registration|
|3:30 pm — 3:35 pm||Welcome and introduction|
|3.35 pm — 3:45 pm||Latest trends in biotech funding|
|3.45 pm — 4:05 pm||Inside the head of a life science investor|
|4.05 pm — 5:00 pm||What’s the best way for a small life science company to raise capital to generate big value?|
|5.00 pm — 6:00 pm||Networking and bell-ringing|
|6.00 pm — 7:30 pm||Nasdaq surgery session|
We’d love for this to be an interactive event based on dialogue between the presenters and audience.
You’re welcome to let us know in advance if there are any particular topics or questions you’d like to ask any of the presenters/panelists. Send us an email at firstname.lastname@example.org.
And, of course, feel free to ask lots of questions at the event.
Adam Kostyal, Nasdaq
Carl Bennet, Carl Bennet AB
Charlotta Gummeson, Sahlgrenska Science park
Erik Gatenholm, Cellink
Homan Panahi, Vator Securities
Johannes Hulthe, Antaros Medical
Klementina Österberg, GU Ventures
magnus Björsne, AZ BioVentureHub